Powered by Scientist.com, VWR offers access to 2,200 CROs

By Melissa Fassbender contact

- Last updated on GMT

VWR customers in the US can now purchase products and services through The VWR Science portal powered by Scientist.com. (Image: Getty/littlehenrabi)
VWR customers in the US can now purchase products and services through The VWR Science portal powered by Scientist.com. (Image: Getty/littlehenrabi)
The VWR Science Portal provides customers with access to the Scientist.com supplier network, including more than 2,200 contract research organizations (CROs).

Scientist.com's online marketplace enables researchers to connect with technical experts in thousands of research areas to purchase custom services and products without legal or finance delay, said Kevin Lustig, PhD, co-founder and CEO of Scientist.com.

This allows scientists to test their ideas more quickly and cheaply​,” he told Outsourcing-Pharma.com.

The goal of the collaboration with VWR, which provides product and service solutions to laboratory and production customers, is to create a “one-stop shop​” for scientists to find and purchase services or products through The VWR Science portal powered by Scientist.com.

Working together with its 13 large pharmaceutical partners and VWR, Scientist.com has been steadily expanding its service offerings to include translational and clinical research services, such as human biospecimen acquisition, biomarker analysis, ​real world evidence (RWE) and toxicology​,” added Lustig.

Scientist.com has offices in San Diego and Boston and recently opened an office in England. The company plans to expand to Japan in 2018.

Related news

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers